glp 1 candidates PDB-101: Molecule of the Month: GLP-1 Receptor Agonists GLP-1 Medications for Weight Loss:
Description
Clinical code support: ePA messages can carry diagnosis codes (ICD-10), lab values, or narrative, depending on the payers system requirements
Since GLP-1 therapies do not act as stimulants, they typically avoid unpleasant side effects such as sleeplessness or nervousness, and their gradual onset makes them safe for long term use
The majority of the switches have been OK
Very low-calorie diets should only be followed under medical supervision
That means ensuring youve got the right evidence, and developing a significant number of dossiers
